Boditech Med Inc. (KOSDAQ:206640)
14,010
-230 (-1.62%)
Aug 14, 2025, 3:30 PM KST
Boditech Med Market Cap
Boditech Med has a market cap or net worth of 305.29 billion as of August 15, 2025. Its market cap has decreased by -24.66% in one year.
Market Cap
305.29B
Enterprise Value
265.58B
Revenue
144.17B
Ranking
n/a
PE Ratio
11.01
Stock Price
14,010.00
Market Cap Chart
Since September 1, 2015, Boditech Med's market cap has increased from 28.15B to 305.29B, an increase of 984.44%. That is a compound annual growth rate of 27.04%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 14, 2025 | 305.29B | -17.21% |
Dec 30, 2024 | 368.76B | -18.12% |
Dec 28, 2023 | 450.36B | 100.01% |
Dec 29, 2022 | 225.17B | -41.09% |
Dec 30, 2021 | 382.21B | -29.94% |
Dec 30, 2020 | 545.55B | 146.19% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Sep 1, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.52T |
Celltrion | 38.58T |
ALTEOGEN | 23.35T |
Yuhan | 8,561.74B |
Peptron | 8,235.61B |
SK Biopharmaceuticals | 7,878.31B |
PharmaResearch | 7,106.52B |
LigaChem Biosciences | 5,666.20B |